Here is the local in-Ireland report — from required governmental filings. The trend is not surprising, but it is unhappy news.
[I usually don’t follow country-by-country year end results — but I’ll always make an exception for my Emerald Isle(!). I feel for my people. . . . right?]
. . . .Accounts just filed by Organon (Ireland) with the Companies Office show that pre-tax profits dropped €50m after revenues decreased by 2.6pc to €792.6m last year.
Numbers employed by the Dublin-based firm last year increased by 70 to 591 with the firm’s staff costs totalling €38.9m.
The Swords plant sells to 44 countries around the world and its main activities on site relate to the manufacture of women’s health products.
The plant is part of the MSD group in Ireland – formerly known as Merck Sharp and Dome – which employs over 2,000 in Ireland today. . . .
So it goes — to be expected, post the Schering-Plough bust-up/yard-sale.